iTeos Therapeutics (ITOS)
(Delayed Data from NSDQ)
$16.16 USD
-0.05 (-0.31%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $16.15 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Earnings News For ITOS
-
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
-
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
-
iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
-
iTeos Reports Second Quarter 2023 Financial Results and Provides Business Updates
-
ITeos Therapeutics, Inc. (ITOS) Reports Q1 Loss, Misses Revenue Estimates
-
iTeos Reports First Quarter 2023 Financial Results and Provides Business Updates
-
ITeos Therapeutics, Inc. (ITOS) Q4 Earnings and Revenues Surpass Estimates
-
iTeos Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
-
ITeos Therapeutics, Inc. (ITOS) Lags Q3 Earnings and Revenue Estimates
-
iTeos Reports Third Quarter 2022 Financial Results and Provides Business Updates
-
ITeos Therapeutics, Inc. (ITOS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
ITeos Therapeutics, Inc. (ITOS) Q2 Earnings and Revenues Lag Estimates
-
ITeos Therapeutics, Inc. (ITOS) Surpasses Q1 Earnings and Revenue Estimates
-
ITeos Therapeutics, Inc. (ITOS) Tops Q4 Earnings and Revenue Estimates
-
ITeos Therapeutics, Inc. (ITOS) Lags Q3 Earnings and Revenue Estimates